TNFSF13B and systemic lupus erythematosus: Belimumab, a humanized immunoglobulin G1λ monoclonal antibody that inhibits BAFF, has been recommended to control SLE, facilitate glucocorticoid tapering/discontinuation and serve as a first‐line therapy in severe SLE patients without major organ involvement [222, 228].